Literature DB >> 10347137

The role of TT virus infection in acute viral hepatitis.

T Kanda1, O Yokosuka, T Ikeuchi, T Seta, S Kawai, F Imazeki, H Saisho.   

Abstract

Recently, transfusion-transmitted virus (TTV) was discovered to be a potential causative agent for non-A-E hepatitis. Little is known about the relation between TTV and the clinical courses of various types of acute viral hepatitis. One hundred twenty-five patients with acute viral hepatitis who were admitted to the Chiba University Hospital between 1984 and 1998 and 100 persons with normal liver function tests were tested for the presence of TTV in their sera. Serum samples were tested for TTV DNA and genotype by polymerase chain reaction (PCR). TTV DNA was detected in 15 of 35 patients (43%) with non-A-E hepatitis, 14 of 33 patients (42%) with hepatitis C, 8 of 28 patients (29%) with hepatitis A, 7 of 29 patients (24%) with hepatitis B, and 37 of 100 subjects with normal liver function tests (37%). The detection rate did not differ statistically between non-A-E hepatitis and hepatitis A, B, C, or controls. The distribution of TTV genotypes was similar in non-A-E, A, B, C types, and controls. The clinical characteristics of the acute illnesses were similar for patients with or without TTV in hepatitis non-A-E, A, B, or C. Although TTV was detected frequently in non-A-E acute hepatitis, no etiologic role for TTV could be established.

Entities:  

Mesh:

Year:  1999        PMID: 10347137     DOI: 10.1002/hep.510290613

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Prevalence and genotypic variability of TTV in HIV-infected patients.

Authors:  K E Sherman; S D Rouster; J Feinberg
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

Review 2.  Transfusion transmitted virus: A review on its molecular characteristics and role in medicine.

Authors:  M Irshad; Y K Joshi; Y Sharma; I Dhar
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

3.  High prevalence of TT virus in human bile juice samples: importance of secretion through bile into feces.

Authors:  M Itoh; H Shimomura; S Fujioka; M Miyake; H Tsuji; F Ikeda; T Tsuji
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

4.  Prevalence and phylogenetic analysis of TT virus DNA in Western India.

Authors:  V A Arankalle; S S Gandhe; T M Deshmukh; M S Chadha; A M Walimbe
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

Review 5.  Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans.

Authors:  M Bendinelli; M Pistello; F Maggi; C Fornai; G Freer; M L Vatteroni
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  Weak association between SEN virus viremia and liver disease.

Authors:  Hideo Yoshida; Naoya Kato; Yasushi Shiratori; Runxuan Shao; Yue Wang; Shuichiro Shiina; Masao Omata
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

7.  Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B.

Authors:  Tatsuo Kanda; Masami Shinozaki; Hidehiro Kamezaki; Shuang Wu; Shingo Nakamoto; Makoto Arai; Keiichi Fujiwara; Nobuaki Goto; Fumio Imazeki; Osamu Yokosuka
Journal:  Int J Med Sci       Date:  2011-11-10       Impact factor: 3.738

8.  Molecular epidemiology and genotyping of TT virus isolated from Saudi blood donors and hepatitis patients.

Authors:  Maha A Al-Mozaini; Mohammed N Al-Ahdal; George Kessie; Damian M Dela Cruz; Mohammed A Rezeig; Fahad J Al-Shammary
Journal:  Ann Saudi Med       Date:  2006 Nov-Dec       Impact factor: 1.526

9.  Increased prevalence of anellovirus in pediatric patients with fever.

Authors:  Erin McElvania TeKippe; Kristine M Wylie; Elena Deych; Erica Sodergren; George Weinstock; Gregory A Storch
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Age-specific prevalence, transmission and phylogeny of TT virus in the Czech Republic.

Authors:  Martina Saláková; Vratislav Nemecek; Jaroslav König; Ruth Tachezy
Journal:  BMC Infect Dis       Date:  2004-12-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.